Skip to main content

Delegation Program

The program will be finalized based on the composition of the delegation, stakeholder availability and participating companies’ priorities. The agenda below is indicative and subject to change. Activities, hosts and formats will be confirmed as the program develops.

​​Day

Location

Theme

Agenda highlights

Day 1 | Thu 4 March

Hong Kong

Ecosystem and clinical research

•09:00 Welcoming briefing by Business Sweden
•10:30 Hong Kong biotech ecosystem dialogue
•14:00 Visit to HSITP, incl. AstraZeneca Hong Kong and the GBA International Clinical Trial Institute

Day 2 | Fri 5 March

Hong Kong

Investors and industry

•09:00 / 10:30 / 14:00 Meetings with three biotech investors – pipeline pitches, financing criteria and market insights
•16:00 Pharmaceutical / biotech industry dialogue on collaboration and co-development

Sat–Sun | 6–7 March

HK / Shanghai

Free weekend

•Outside programme scope – participants travel to Shanghai by 7 March at their own arrangement

Day 3 | Mon 8 March

Shanghai

Investors, R&D and clusters

•09:30 Meeting with a biotech investor
•11:00 Meeting with AstraZeneca China R&D
•13:30 Meeting with a leading biotech company in China #1
•15:00 Visit to Zhangjiang Biotech Park

Day 4 | Tue 9 March

Shanghai → Suzhou

Industry, legal and networking

•09:30 Meeting with a leading biotech company in China #2
•11:00 Meeting with a leading legal adviser in the biotech sector
•12:30 Networking lunch hosted by the Consulate General of Sweden in Shanghai
•Afternoon: free time; high-speed train to Suzhou

Wed–Fri | 10–12 March

Suzhou

BIOCHINA 2027

•Morning bus from hotel in Suzhou to BIOCHINA; conference and exhibition access for the pass holder
•Each company submits its own meeting requests via the BIOCHINA’s official platform – acceptance rests with the counterpart
•Compact shared Swedish booth (approx. 9 sqm) focused on company logos, video promotion and use as a common meeting point
•Possible side visit to a company in Suzhou (TBC, one day only)


Target Stakeholder Types

The stakeholder program will be developed based on the composition and priorities of the delegation, as well as stakeholder relevance, interest and availability.

The following stakeholder types are illustrative and do not represent confirmed meetings or participating organizations:

  • Investors and industry partners, including life science investors, pharmaceutical companies and biotechnology companies
  • Research and innovation stakeholders, including universities, research institutes, science parks, biotech clusters and innovation platforms
  • Industry experts and professional advisers, including specialists in intellectual property, partnering, transactions, financing and relevant industry developments

Specific organizations and engagements will be confirmed as the program develops and remain subject to stakeholder interest and availability.